• Carvedilol Phosphate in Hepatic IRI Models

  2026-09-10

  Carvedilol Phosphate gives researchers a controllable non-selective beta blocker perturbation for connecting GPCR signaling with hepatocyte stress and macrophage responses. This guide translates recent Arrb2–6-ketoLCA findings into formulation, ischemia–reperfusion injury model, assay-design, and troubleshooting strategies without overstating the evidence.

• EZ Cap Cy5 Firefly Luciferase mRNA: Assay Logic

  2026-09-10

  EZ Cap Cy5 Firefly Luciferase mRNA combines Cy5-based delivery tracking with luciferase-based functional expression. This article presents a decision-oriented assay framework linking reporter readouts to LNP design, translation efficiency, and findings from recent ocular genome-editing research.

• Abiraterone acetate in 3D Prostate Models

  2026-09-09

  Build a formulation-aware workflow for testing a CYP17 inhibitor in patient-derived prostate spheroids, from tissue processing through androgen-response readouts. The approach distinguishes target engagement from 3D delivery limits and helps explain why organ-confined models may respond differently from conventional cell lines.

• Hematoxylin and Eosin Staining: K1142 Guide

  2026-09-09

  The Hematoxylin and Eosin staining workflow uses complementary dyes to visualize nuclei, cytoplasm, extracellular matrix, and tissue architecture. The H&E staining kit K1142 supplies ready-to-use solutions for research workflows involving paraffin-embedded sections, frozen sections, and cytological preparations.

• ARCA Cy5 EGFP mRNA: Assay Design Guide

  2026-09-08

  ARCA Cy5 EGFP mRNA (5-moUTP) enables a practical framework for separating cellular uptake from productive translation. Learn how to design rigorous delivery assays and apply insights from biodegradable polyester nanoparticles for ischemia research.

• CK2 Phosphorylation Tunes Plant Ceramide Synthase

  2026-09-08

  The reference study shows that CK2 phosphorylation regulates Arabidopsis LOH2 at two C-terminal serines, increasing catalytic activity while accelerating polyubiquitination and proteasomal turnover. This dual control links ceramide production with salicylic acid accumulation, cell death, and resistance to fungal and bacterial challenges.

• B7H3×CD3 BiTE mRNA-LNPs in Solid and Blood Cancers

  2026-09-07

  The reference study developed an ionizable lipid nanoparticle system for delivering mRNA encoding a B7H3×CD3 bispecific T-cell engager. Its central finding was that one intravenous administration produced substantial in vivo BiTE expression, extended exposure, and durable antitumor activity in models of hematologic malignancy and melanoma.

• PSMD14–CARM1 Axis in Hepatocellular Carcinoma

  2026-09-07

  This study identifies PSMD14-mediated deubiquitination as a mechanism that elevates CARM1 in hepatocellular carcinoma and connects CARM1 activity to FERMT1 transcription through H3R17 dimethylation. The findings define a PSMD14–CARM1–FERMT1 pathway that promotes tumor growth and metastasis and provide pharmacological support for targeting CARM1.

• Reserpine N1867: Practical Lab Workflow Guide

  2026-09-05

  Reserpine (SKU N1867) provides a defined research reagent for neurotransmitter depletion, antihypertensive mechanism, and neuropharmacology workflows where controlled solubilization and fresh-solution handling are important. It is intended for laboratory research only, not for diagnostic, therapeutic, medical, or veterinary use.

• Tomivosertib: From eIF4E Signal to Assay Design

  2026-09-04

  Tomivosertib is a potent MNK1 inhibitor for resolving how MNK-dependent eIF4E phosphorylation connects tumor-cell survival with glioblastoma angiogenesis. This guide translates the key glioblastoma evidence into practical model-selection, control, and assay-interpretation strategies.

• Naftifine HCl: Designing Better Antifungal Assays

  2026-09-04

  Naftifine HCl is an allylamine antifungal agent whose value extends beyond routine growth inhibition assays. This guide explains how to connect sterol-pathway biology, orthogonal readouts, solvent control, and lessons from multidimensional muscle-cell research to build more interpretable antifungal experiments.

• Moesin as a Biomarker of Endothelial Injury in Sepsis

  2026-09-03

  Chen et al. identified circulating moesin as a marker associated with endothelial injury and sepsis severity, linking serum levels to SOFA scores, procalcitonin, and experimental lung damage. The study also connects moesin to ROCK1/MLC and NF-κB signaling in endothelial cells, providing a mechanistic basis for future biomarker and vascular-barrier research.

• Moxidectin for Antifungal Synergy Research

  2026-09-03

  Moxidectin is an established veterinary antiparasitic now being evaluated as an ergosterol-directed potentiator for polyene antifungal research. This guide translates the finding into practical workflows for Candida growth, biofilm, mechanism, and preclinical validation assays while separating evidence-backed observations from assay-development recommendations.

• From Fluorescent mRNA to Translational Confidence

  2026-09-02

  A thought-leadership guide to using ARCA Cy5 EGFP mRNA (5-moUTP) as a mechanistic bridge between delivery, intracellular localization, and functional translation in mammalian systems, with lessons from targeted mRNA nanoparticles in ischemic stroke.

• Thymosin-β4, Notch/NF-κB, and Limb Ischemia

  2026-09-02

  The reference study shows that thymosin-β4 promotes endothelial activity and angiogenic remodeling in a critical limb ischemia mouse model, with evidence implicating coordinated Notch and NF-κB signaling. Its combination of endothelial-cell assays, pathway inhibitors, and tissue-level measurements provides a useful framework for evaluating pharmacological NF-κB modulation in vascular repair research.

8073 records 1/539 page Next 12345 下5页 Last page